Works from 2020
A case of Barrett’s Esophagus with low-grade dysplasia progressing to esophagealadenocarcinoma despite radiofrequency ablation and vigilant surveillance, David H. Kruchko and Alan B. Shapiro (Poster)
A case of IGG4-related interstitial lung disease manifesting as recurrent necrotizing pneumonia, Ramier Lehne, Duc Ho, and Larry M. Jankelowitz (Poster)
A case of pembrolizumab-induced diabetic ketoacidosis, Christopher Wagner and Debjit Saha (Poster)
Acute hypersensitivity pneumonitis associated with a high Ki-67 proliferative index, Edward Nabrinsky, Amanda Kamar, Dereen Mohammed Saeed, Michael Pins, and Arvey Stone (Article)
Cell death pathways in lymphoid malignancies, Luke Fletcher, Edward Nabrinsky, Tingting Liu, and Alexey Danilov (Article)
De novo inflammatory bowel disease in patients on IL-1 inhibitor therapyfor rheumatologic diseases, Saad Hashmi, Ramier Lehne, Ryan T. Hoff, and Eli Ehrenpreis (Poster)
Diagnostic dilemma: A case of CMV enteritis resulting in severe obscure GI bleeding, David H. Kruchko, Ami P. Patel, Natasha Shah, and Scott Siglin (Poster)
Dysphagia, dyspnea, and diverticulum: A right sided aortic arch withaberrant left subclavian artery, Piotr Wlodkowski, Sasirekha Pandravada, Christopher Wagner, and Elizabeth Klein (Poster)
Effect of intravenous odansetron in hospitalized patients on measured QTC interval, David H Kruchko, Eli Ehrenpreis, and Charles Broy (Article)
Exploring the link between bevacizumab and gastrointestinal perforations using the FDA’s adverse event reporting system database, Thomas Adam Wichelmann, Sufyan Abdulmujeeb, and Eli Ehrenpreis (Poster)
Missed connections: Acquired Gerbode defect after a second mitral valve surgery, Abdel-Rahman Zakieh, Samer Martini, Faisal Masood, and Adib Chaus (Poster)
Primary gastric choriocarcinoma: A case report of early successful treatment outcome, Alyssa Ceilesh, Sarah Burroughs, Nasma Majeed, and Leonard Klein (Article)
Rapid review: nonsteroidal anti-inflammatory agents and aminosalicylates in COVID-19 Infections, Eli Ehrenpreis and David H Kruchko (Article)
Reporting trends of adverse effects from proton pump inhibitors to the food and drug administration, David H Kruchko, Ami P. Patel, Dana Villines, Aleksandar Sujancev, and Eli Ehrenpreis (Article)
The cost-effectiveness of implementing an exercise program for fall and fracture prevention in adults aged 65 and older on proton pump inhibitor therapy, Thomas Adam Wichelmann, Nhan Dang, David Kruchko, Sufyan Abdulmujeeb, and Eli Ehrenpreis (Poster)